GSE238018 MXRA8 knockout MDA-MB-231 1 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE238018_MXRA8 knockout_MDA-MB-231_1_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE238018_MXRA8 knockout_MDA-MB-231_1_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE238018_MXRA8 knockout_MDA-MB-231_1_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE238018_MXRA8 knockout_MDA-MB-231_1_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

double homeobox A pseudogene 8

Gene

long intergenic non-protein coding RNA 511

Gene

urothelial cancer associated 1

Gene

MIR34A host gene

Gene

tripartite motif containing 31

Gene

AFAP1 antisense RNA 1

Gene

WAP four-disulfide core domain 21, pseudogene

Gene

ITGB2 antisense RNA 1

Gene

APCDD1L divergent transcript

Gene

SOX21 antisense RNA 1

  • Gene

    double homeobox A pseudogene 8


  • Gene

    long intergenic non-protein coding RNA 511


  • Gene

    urothelial cancer associated 1



  • Gene

    tripartite motif containing 31


  • Gene

    AFAP1 antisense RNA 1


  • Gene

    WAP four-disulfide core domain 21, pseudogene


  • Gene

    ITGB2 antisense RNA 1


  • Gene

    APCDD1L divergent transcript


  • Gene

    SOX21 antisense RNA 1

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.